Get started
Author

Noa Esther Wijnen

Actigraphic estimates of sleep and the sleep-wake rhythm, and 6-sulfatoxymelatonin levels in healthy Dutch children
2020 · Niki Rensen, Lindsay M. H. Steur, et al. · Chronobiology International · 22
Chip-AML22 Master Protocol: An Open-Label Clinical Trial in Newly Diagnosed Pediatric De Novo Acute Myeloid Leukemia (AML) Patients Including a Linked Phase II Trial with Quizartinib in FLT3 -ITD/ NPM1 wt Patients - a Study By the NOPHO-DB-SHIP Consortium
2023 · Gertjan J.L. Kaspers, Noa E. Wijnen, et al. · Blood · 8
Treatment outcomes of pediatric acute myeloid leukemia in Western Kenya before and after the implementation of the SIOP PODC treatment guideline
2023 · Romy E. van Weelderen, Noa E. Wijnen, et al. · Cancer Reports · 7
PDF
Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin
2023 · Noa E Wijnen, Joost B Koedijk, et al. · OncoTargets and Therapy · 5
PDF
Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia
2024 · Farnaz Barneh, Joost B. Koedijk, et al. · Haematologica · 4
PDF
Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature
2025 · Noa E. Wijnen, Daan J. Touw, et al. · British Journal of Clinical Pharmacology · 1
Pediatric AML in Resource-Limited Countries
2024 · Noa E. Wijnen, Festus Njuguna, et al. · Pediatric oncology · 1
Childhood cancer care beyond the ‘six common and curable types’: A comparative case series on acute myeloid leukemia in Kenya and the Netherlands
2024 · Noa Wijnen, Larissa Klootwijk, et al. · Asia-Pacific Journal of Oncology Nursing · 1
Early Peripheral Blood Blast Clearance As a Prognostic Marker for Early Treatment Response in Pediatric Acute Myeloid Leukemia
2023 · Noa E. Wijnen, Bianca de Boer, et al. · Blood · 1
PDF
Premature treatment cessation in pediatric acute myeloid leukemia due to excessive toxicity: clinical experiences and patient outcomes — a case series
2026 · Coen van de Groep, Merlijn van Hamel, et al. · Figshare
Premature treatment cessation in pediatric acute myeloid leukemia due to excessive toxicity: clinical experiences and patient outcomes — a case series
2026 · Coen van de Groep, Merlijn van Hamel, et al. · Pediatric Hematology and Oncology
PDF
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium
2026 · Gertjan J.L. Kaspers, Merlijn van Hamel, et al. · Trials
Cure and Care: A Delicate Balance in Global Pediatric Acute Myeloid Leukemia
2026 · Noa Esther Wijnen
CARE study: prospective cohort study on supportive care among paediatric oncology patients in western Kenya—a study protocol
2026 · Alice Gichemi, Noa Esther Wijnen, et al. · BMJ Open
Early peripheral blood blast clearance is a prognostic marker for early treatment response and long-term outcome in pediatric Acute Myeloid Leukemia
2025 · Noa Wijnen, Bianca de Boer, et al. · Blood
P437: Effective Immunotherapy of Pediatric T(8;21) Acute Myeloid Leukemia by Repurposing Cd3xcd19 Targeting Bispecific Antibodies
2023 · Noa Wijnen, Farnaz Barneh, et al. · HemaSphere
CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia
2023 · F Barneh, T Meulendijks, et al. · Klinische Pädiatrie
Works count: 17
Citation count: 50
H-index: 4
I10-index: 1
Year
Topic
Type